In this work, the authors generated CBCT based stopping power distributions using DIR of the pCT to a CBCT scan. DIR accuracy was below 1.4 mm as evaluated by the SIFT algorithm. Dose distributions calculated on the vCT agreed well to those calculated on the rpCT when using gamma index evaluation as well as DVH statistics based on the same contours. The use of DIR generated contours introduced variability in DVH statistics.

PK is a stakeholder in SeeTreat, a start-up company to commercialize intellectual property generated through NHMRC program grant APP1036075 "The Australian MRI-Linac program".

The integration of magnetic resonance imaging (MRI) for guidance in external beam radiotherapy has faced significant research and development efforts in recent years. The current availability of linear accelerators with an embedded MRI unit, providing volumetric imaging at excellent soft tissue contrast, is expected to provide novel possibilities in the implementation of image-guided adaptive radiotherapy (IGART) protocols. This study reviews open medical physics issues in MR-guided radiotherapy (MRgRT) implementation, with a focus on current approaches and on the potential for innovation in IGART. Daily imaging in MRgRT provides the ability to visualize the static anatomy, to capture internal tumor motion and to extract quantitative image features for treatment verification and monitoring. Those capabilities enable the use of treatment adaptation, with potential benefits in terms of personalized medicine. The use of online MRI requires dedicated efforts to perform accurate dose measurements and calculations, due to the presence of magnetic fields. Likewise, MRgRT requires dedicated quality assurance (QA) protocols for safe clinical implementation. Reaction to anatomical changes in MRgRT, as visualized on daily images, demands for treatment adaptation concepts, with stringent requirements in terms of fast and accurate validation before the treatment fraction can be delivered. This entails specific challenges in terms of treatment workflow optimization, QA, and verification of the expected delivered dose while the patient is in treatment position. Those challenges require specialized medical physics developments towards the aim of fully exploiting MRI capabilities. Conversely, the use of MRgRT allows for higher confidence in tumor targeting and organs-at-risk (OAR) sparing. The systematic use of MRgRT brings the possibility of leveraging IGART methods for the optimization of tumor targeting and quantitative treatment verification. Although several challenges exist, the intrinsic benefits of MRgRT will provide a deeper understanding of dose delivery effects on an individual basis, with the potential for further treatment personalization.

No abstract

Over the last few decades, deformable image registration (DIR) has gained popularity in image-guided radiation therapy for a number of applications, such as contour propagation, dose warping, and accumulation. Although this raises promising perspectives for the improvement of treatment outcomes and quality of radiotherapy clinical practice, the variety of proposed DIR algorithms, combined with the lack of an effective quantitative quality control metric of the registration, is slowing the transfer of DIR into the clinical routine. Recently, a task group (AAPM TG132) report was published outlining the essential aspects of DIR for image guidance in radiotherapy. However, an accurate and efficient patient-specific validation is not yet defined, and appropriate metrics should be identified to achieve the definition of both geometric and dosimetric accuracy. In this respect, the use of a dense set of anatomical landmarks, along with additional evaluations on contours or deformation field analysis, are likely to drive patient-specific DIR validation in clinical image-guided radiotherapy applications to account for geometric inaccuracies. Automatic and efficient strategies able to provide spatial information of DIR uncertainties and to evaluate monomodal and multimodal image registration, as well as to describe homogenous and un-contrasted regions are believed to represent the future direction in DIR validation. But especially in the case of DIR applications for dose mapping and accumulation, the need of accurate patient-specific validation is not only limited to the evaluation of geometric accuracy. In fact, the need to account for dosimetric inaccuracies due to DIR represents another important area in the field of adaptive treatments. Different approaches are currently being investigated to quantify the effect of DIR error on dose analysis, mainly relying on clinically relevant dose metrics, or on the study of deformation field properties for a voxel-by-voxel evaluation. However, novel research is required for the definition of dedicated and personalized measures capable to relate the geometric and dosimetric inaccuracies, thus bearing useful information for a safe use of DIR by clinical end users. In this paper we provide insights on DIR results evaluation on a patient-specific basis, facing the issues of both geometric and dosimetric paradigms. Challenges on DIR validation are overviewed and discussed, in order to push preliminary clinical guidelines forward on this fundamental topic and boost the implementation of more robust and reliable patient-specific evaluation metrics.